This cross-sectional study describes potential reductions in out-of-pocket costs for generic medications among Medicare beneficiaries.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: